The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...

Experts fear a resurgence of infections in low-income countries if the ban were to continue. The waiver remains in place, ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for ...

Chronic obstructive pulmonary disease (COPD) and other lower respiratory diseases are among leading causes of U.S. deaths per ...